PreciseDx
is a New York-based AI platform that provides solutions such as cancer risk stratification and personalized treatment analytics for the healthcare industry... Read morePreciseDx
is a New York-based AI platform that provides solutions such as cancer risk stratification and personalized treatment analytics for the healthcare industry... Read more
News
Nov 20, 2024
Citybizlist
PreciseDx: PreciseDx Announces Formation of Scientific Advisory Board
Aug 27, 2024
Crain's Newyork Business
PreciseDx: Mount Sinai for-profit spin-off raises $21M for diagnostic tech using vast sums of patient data
Aug 27, 2024
Beckers Hospital Review
PreciseDx: Mount Sinai Health System AI spinoff lands $21M
Aug 27, 2024
citybiz
PreciseDx: PreciseDx Uses AI to Predict Recurrence of Breast Cancer
Aug 21, 2024
FinSMEs
PreciseDx: PreciseDx Raises $20.7M in Series B Funding
May 30, 2024
Medical Device Network
PreciseDx: COTA, Baptist Health and PreciseDx collaborate on breast cancer test
May 28, 2024
PR Newswire
Press Release: PreciseDx : PreciseDx Announces Poster Presentation at The 2024 American Society of Clinical Oncology Annual Meeting
Apr 08, 2024
HIT Consultant Media
PreciseDx: UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection
Mar 22, 2024
PRWeb
PreciseDx: PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference
Mar 08, 2023
PR Newswire
Press Release: PreciseDx : PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting
